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INTRODUCTION
Vulvar cancer is rare, mostly afflicting women aged 60
and older [1]. The cancer is often preceded by a
common vulvar rash, Lichen sclerosis, that is often
treated with the ultra-potent corticosteroid, clobetasol
propionate. This treatment may, in turn, be associated
with vulvar carcinogenesis. Our previous findings
suggest that initial clobetasol exposure can result in a
state of quiescence in UMSCV-4 cells and that long term
clobetasol exposure selects for cell subpopulations that
are unable to re-enter quiescence upon clobetasol
re-exposure [5]. Quiescence is a temporary removal
from the cell cycle and can be thought of as a dormant
state in which cells are not actively dividing [2]. There is
growing evidence suggesting that quiescence may play
a role in allowing cancer cells to contribute to the
recurrence of the cancer months or years after treatment
[3]. There are several cell cycle inhibitors that may
indicate quiescence, including p16, p21, p53, and p27
[4]. Preliminary studies in our lab suggest that p16, p21,
and p53 do not play a clear role in clobetasol-induced
quiescence of UMSCV-4 cells. The role of p27 in
quiescence of UMSCV-4 cells also does not appear to
be straightforward, and further studies confirming these
results and exploring other signaling pathways related to
quiescence are necessary.
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Figure 1. Re-exposure of UMSCV-4 cells to clobetasol results in resistance to the
growth inhibition effects of clobetasol. This model represents the process that led to
generation of the long-term, clobetasol “resistant” UMSCV-4 cells. Untreated UMSCV-4
cells were exposed to clobetasol for 3 months during which time the clobetasol medium
was refreshed periodically to account for evaporation but the cells were not removed or
passaged. After 3 months the clobetasol was removed and cells were allowed to
“recover” for 4 weeks in medium not containing ethanol or clobetasol. Note that mitotic
cells were visible within 3 days of clobetasol removal. After 4 weeks proliferating cells
were re-exposed to clobetasol. These cells did not experience the growth arrest seen
when originally exposed to clobetasol. This population of cells is referred to as

ONCLUSION
FURTHER STUDIES
C

Figure 3. Cell cycle inhibitors p16, p21, and p53 do not appear to play a direct role
in clobetasol-induced UMSCV-4 cell quiescence. A) RT-PCR gene expression
analysis of p16, p21, and p53 in clobetasol treated NT cells. B) RT-PCR gene
expression analysis of p16, p21, and p53 in clobetasol treated LT cells. We would
expect the levels of the aforementioned cell cycle inhibitors to be upregulated upon
initial clobetasol exposure in NT cells that typically enter quiescence, and
downregulated in LT cells that are typically unable to re-enter quiescence. Initial results
do not demonstrate this relationship or any other clear relationship between the
regulation of these inhibitors and clobetasol exposure.

Cells were examined for changes in mRNA expression of key markers
indicative of entering a state of quiescence via RT-PCR. Clobetasol was
diluted in 95% ethanol (10-7 M final concentration) and UMSCV-4 cells
were cultured in the presence (+clob) or absence of clobetasol (-clob
+EtOH) for these experiments. UMSCV-4 LT cell populations were
generated as described in Figure 1.
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❏ We would expect NT cells exposed to clobetasol to upregulate cell
cycle inhibitors, since these cells are temporarily growth arrested
when exposed to clobetasol [5]. There does not appear to be a
clear correlation between the upregulation of the cell cycle
inhibitors, p16, p21, p53, and p27 upon initial clobetasol exposure
in NT cells.
❏ We would expect LT cells exposed to clobetasol to downregulate
cell cycle inhibitors, as we have previously demonstrated these
cells appear unable to re-enter quiescence [5]. There does not
appear to be a clear correlation between the downregulation of the
cell cycle inhibitors, p16, p21, p53, and p27 upon clobetasol
re-exposure in LT cells.
❏ It is possible that the aforementioned cell cycle inhibitors do not
play a role in UMSCV-4 cell quiescence, as previous studies have
demonstrated quiescence can relieve the requirement for Notch
signaling in certain cell types [6]. Quiescence could also relieve the
requirement for p16, p21, p53, and p27 inhibitors, and this could
explain our otherwise unexpected results.

UMSCV-4 LT.

MATERIALS & METHODS

The basic procedure for examination of clobetasol effects on UMSCV-4 NT
and UMSCV-4 LT cells was as follows
❏ EtOH 10d: Ethanol treated (same concentration as would be found for
the clobetasol containing medium) for 10 days
❏ Clob10d: Treated with clobetasol for 10 days
❏ Clob 6d-4d: Treated with clobetasol for 6 days and changed to ethanol
containing medium for 4 days
❏ Cells from each group were subsequently harvested and tested using
protocols described in each figure.
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Figure 2. UMSCV-4 untreated cells (no treatment) show a decrease in
proliferation and changes in morphology when treated with clobetasol
while the long-term cells (see Figure 1) showed little change in growth rate
or morphology. UMSCV-4 untreated cells (NT) or long-term (LT) were exposed
to clob for 10 days (+clob 10 day, panels A and D) or to clob for 6 days followed
by treatment with ethanol for a subsequent 4 days (+clob 6 day, 4 day, panels B
and E) or to vehicle alone for the full 10 days (+EtOH, panels C and F). Clob
treatment of the untreated cells caused the cell morphology to become more
neuronal-like and many of the cells became vacuolated (panel A). The growth
rate also decreased [5]. When the cells were treated for 6 days and then
removed from clob the cells did not recover their normal morphology (panel B)
but several patches of mitotic cells began to appear at day 4 post treatment [5].
Cells that were grown in the presence of vehicle (+EtOH, panel C) did not show
any morphological changes nor growth arrest. The LT cells grew at basically the
same rates whether in clob for 10 days (panel D), clob for 4 days followed by
EtOH only (panel E) or in EtOH for the full 10 days (panel F). Total RNA was
extracted from these cells and used for subsequent RT-PCR as described in
subsequent figures.
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Figure 4. Cell cycle inhibitor, p27, does not appear to play a direct role in
clobetasol-induced quiescence in UMSCV-4 cells, although it is slightly upregulated
after 10 days exposure to clobetasol in NT cells. A) RT-PCR gene expression analysis
of p27 in clobetasol treated NT cells. B) RT-PCR gene expression analysis of p27 in
clobetasol treated LT cells. We would expect the levels of the p27 to be upregulated upon
initial clobetasol exposure in NT cells that typically enter quiescence, and downregulated in
LT cells that are typically unable to re-enter quiescence. Initial results do not demonstrate
this relationship or any other clear relationship between the regulation of these inhibitors
and clobetasol exposure.

❏ Further research will focus on repeating RT-PCR examining p16, p21,
p53, and p27 expression, as we need to have a larger number of
trials in order to determine statistical significance of our results.
❏ Further research will study the role of Notch signaling in clobetasol
treated NT and LT cells. If our results are consistent with previous
studies examining Notch signaling in quiescent cells, it is possible
that quiescence relieves the requirement for both Notch signaling and
the cell cycle inhibitors we studied [6].
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